Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00589810 · ClinicalTrials.gov registry record
Whole Genome Association Study to Identify and Validate Genes for Restenosis: CardioGene Validation Proposal
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 761
- Enrollment target
NCT00589810 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 761 participants.
The verdict
NCT00589810 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 761 participants
- Enrollment target
Study Summary
In this replication study at the Cleveland Clinic, we seek to collaborate to validate findings of the CardioGene Study in an independent cohort of patients who have undergone bare metallic stenting.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 761 participants |
| Start Date | 2007-08 |
| Est. Completion | 2011-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00589810
The ClinicalTrials.gov registry entry for NCT00589810 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 761 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00589810 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00589810 about?
NCT00589810 is a clinical study titled "Whole Genome Association Study to Identify and Validate Genes for Restenosis: CardioGene Validation Proposal". In this replication study at the Cleveland Clinic, we seek to collaborate to validate findings of the CardioGene Study in an independent cohort of patients who have undergone bare metallic stenting.
What is the current status of trial NCT00589810?
This trial is currently completed. The enrollment target is 761 participants. The study started on 2007-08. Estimated completion is 2011-11.
Who is sponsoring clinical trial NCT00589810?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.